运脾活血散结方改善糖尿病心肌病的药效评价与计算识别机制研究
该研究在糖尿病心肌病(DCM)大鼠模型中验证运脾活血散结(YP-SJ)方的体内心肌保护作用,并通过网络药理学与体内外实验探索其机制。结果显示YP-SJ方可改善心脏收缩功能,鉴定出46个与DCM进展相关的主要候选靶点,并证实其通过激活FoxO1信号通路调控自噬而发挥心脏保护作用。
要点
- YP-SJ方灌胃10周可有效改善DCM大鼠心脏收缩功能。
- 鉴定出46个与DCM进展相关的主要候选靶点,富集于环境信息处理、有机系统及活性氧代谢。
- YP-SJ方通过上调FoxO1、Atg7、Beclin 1、LC3并降低磷酸化FoxO1激活FoxO1信号通路调控自噬。
核心结论
- YP-SJ方通过调节自噬关键靶点、以多成分多靶点多通路多机制方式改善DCM大鼠心肌功能。
研究设计与样本
- DCM大鼠随机分为5组:对照组、模型组及YP-SJ方低、中、高剂量组(分别6、12、24 g/kg/d灌胃10周)。
- 细胞分为对照组、高糖组、高糖+对照血清组、高糖+含药血清组、高糖+NC-siRNA组、高糖+siRNA-FoxO1组。
- 采用高分辨率小动物成像系统测定大鼠心脏功能,并通过流式细胞术、免疫荧光和蛋白质印迹检测自噬程度。
主要发现
- YP-SJ方可有效改善DCM大鼠心脏收缩功能。
- 鉴定出46个与DCM进展密切相关的主要候选YP-SJ方靶点,富集分析涉及环境信息处理、有机系统和活性氧代谢。
- 体内外实验证实YP-SJ方可上调FoxO1、Atg7、Beclin 1和LC3表达,降低磷酸化FoxO1表达,激活FoxO1信号通路。
- 进一步实验表明YP-SJ方通过调控自噬改善心脏功能。
临床怎么用
- 在DCM大鼠模型中,YP-SJ方灌胃剂量分别为6、12、24 g/kg/d、疗程10周,可改善心脏收缩功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Yunpi-Huoxue-Sanjie (YP-SJ) formula is a Chinese herbal formula with unique advantages for the treatment of diabetic cardiovascular complications, such as Diabetic cardiomyopathy (DCM). However, potential targets and molecular mechanisms remain unclear. Therefore, our research was designed to evaluate rat myocardial morphology, fat metabolism and oxidative stress to verify myocardial protective effect of YP-SJ formula in vivo. And then to explore and validate its probable mechanism through network pharmacology and experiments in vitro and in vivo. Methods: In this study, DCM rats were randomly divided into five groups: control group, model group, and three YP-SJ formula groups (low-dose, middle-dose, and high-dose groups). Experimental rats were treated with 6 g/kg/d, 12 g/kg/d and 24 g/kg/d YP-SJ formula by gavage for 10 weeks, respectively. Cardiac function of rats was measured by high-resolution small-animal imaging system. The cells were divided into control group, high glucose group, high glucose + control serum group, high glucose + dosed serum group, high glucose + NC-siRNA group, high glucose + siRNA-FoxO1 group. The extent of autophagy was measured by flow cytometry, immunofluorescence, and western blotting. Results: It was found that YP-SJ formula could effectively improve cardiac systolic function in DCM rats. We identified 46 major candidate YP-SJ formula targets that are closely related to the progression of DCM. Enrichment analysis revealed key targets of YP-SJ formula related to environmental information processing, organic systems, and the metabolic occurrence of reactive oxygen species. Meanwhile, we verified that YP-SJ formula can increase the expression of forkhead box protein O1 (FoxO1), autophagy-related protein 7 (Atg7), Beclin 1, and light chain 3 (LC3), and decrease the expression of phosphorylated FoxO1 in vitro and in vivo. The results showed that YP-SJ formula could activate the FoxO1 signaling pathway associated with DCM rats. Further experiments showed that YP-SJ formula could improve cardiac function by regulating autophagy. Conclusion: YP-SJ formula treats DCM by modulating targets that play a key role in autophagy, improving myocardial function through a multi-component, multi-level, multi-target, multi-pathway, and multi-mechanism approach.
引用
- Zhang X, You LY, Zhang ZY, et al. Integrating pharmacological evaluation and computational identification for deciphering the action mechanism of Yunpi-Huoxue-Sanjie formula alleviates diabetic cardiomyopathy. Front Pharmacol. 2022. PMID: 36147338. doi:10.3389/fphar.2022.957829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。